Letters
- 2012
- 09 May 2012 HAI Europe Formindep Joint Letter to MEPs to Postpone the decision on the discharge of the European Medicines Agency’s 2010 accounts
- 20 Mar 2012 Health Action International Commentary Johnson & Johnson rejection of the Medicines Patent Pool: what will the ATMi say now?
- 08 Feb 2012 Joint Letter to House Committee on Oversight and Government Reform about the “Research Works Act”
- 2011
- 22 Dec 2011 Open letter to Kamercommissie EL & I regarding ACTA
- 27 Oct 2011 HAI Europe, PC and KEI Joint Submission to Global Commission on HIV and the Law
- 10 Oct 2011 HAI Europe letter to ECA Mr E. O’Shae
- 29 Jun 2011 Joint Open letter on the Common Strategic Framework for EU Research and Innovation Funding
- 20 Jun 2011 Joint Open Letter to Commissioner Dalli on conflicts of interest at the European Medicines agency and the need for a review of staff regulations
- 24 May 2011 NGO letter on Conflicts of Interest, Future Financing, Reform and Governance of the WHO
- 20 May 2011 Joint Open Letter to Commissioner Dalli on Information to Patients
- 20 May 2001 ANNEX 1 to Joint Open letter to Commissioner Dali on Information to Patients
- 09 May 2011 Joint Open Letter Support for Audit of European Medicines Agency by the European Court of Auditors
- 22 Mar 2011 HAI Europe Endorses KEI Complaint to UN Rapporteur on the Right to Health About the Trans-Pacific Partnership Agreement
- 24 Feb 2011 Joint Open Letter to Commissioner Dalli Concerning Conflict of Interest for Former EMA Executive Director
- 22 Feb 2011 Open Letter to Novartis
- 2 Feb 2011 Letter to the Dutch Minister of Health, Wellness and Sport Regarding Relationships Between the Pharamceutical Industry and Patient Organisations in the Netherlands
- 2010
- 29 Jul 2010 Open Letter to Commissioner van de Gucht on ACTA
- 27 Jul 2010 Letter to Australian Parliamentary Secretary of Health
- 6 May 2010 HAI Europe Letter of Support for EU H1N1 Inquiry
- 1 Mar 2010 Joint Letter to Commissioner Dalli on ‘Info’ to Patients Proposals
- 11 Jan 2010 Open Letter to Commissioner De Gucht on Joint Declaration + Joint Declaration Trading Away Access to Medicines with Endorsements
- 2009
- 19 Dec 2011 Open Letter to Mr Dalli concerning new evidence in Lonngren case
- 19 Dec 2011 Open letter to Mr Rasi concerning the Staff Regulations at EMA
- 15 Sep 2009 Letter for Australian MP TGA Meeting on Drug Promotion Regulation
- 23 Apr 2009 Open Letter from EU-CAN Alliance to European Council + Annex 1 + Annex 2
- 18 Feb 2009 Open Letter to World Trade Organization on Dutch seizure of Generic Medicines
- 18 Feb 2009 Open Letter to World Health Organization on Dutch seizure of generic Medicines
- 10 Feb 2009 Open Letter Dutch Seizure of Generic Medicines (EN)
- 10 Feb 2009 Open Letter Dutch seizure of Generic Medicines (NL)
- 9 Feb 2009 Open Letter to the European Commission from EU-CAN Alliance + Annex
- 2008
- 5 Dec 2008 Joint AIM-HAI-MiEF Letter to President Barroso on the Pharmaceuticals Package
- 26 Nov 2008 Letter La transparence de l’Information Médicale (FR)
- 19 Nov 2008 Joint Open letter to President Barroso on Pharmaceuticals Package
- 15 Oct 2008 Letter to the EU Commission on Proposed ‘information to Patients’ Modifications
- 31 Mar 2008 Joint Open Letter to Commissioners on ‘Information to Patients’ Proposals (EN)
- 31 Mar 2008 Joint Open Letter to Commissioners on ‘Information to Patients’ Proposals (FR)
- 31 Mar 2008 Joint Open letter to MEPs on ‘Information to Patients’ Proposals (EN)
- 31 Mar 2008 Joint Open letter to MEPs on ‘Information to Patients’ Proposals (FR)
Consultation Responses
- 2011
- 30 Nov 2011 HAI Europe Consultation Response to the European Research Area Framework
- 31 Aug 2011 HAI Europe and MIEF Response to the HMA/EMA Guidance document on the identification of Commercially Confidential Information and Protection of Personal Data within the structure of the Marketing Authorisation (MA) Dossier
- 01 Jul 2011 HAI Europe Consultation Response to the European Medical Agency on ethical and GCP aspects of clinical trials in third countries
- 30 May HAI Europe Consultation Response on Health Threats
- 25 May 2011 HAI Europe Consultation Response Transparency Directive
- 20 May 2011 HAI Europe Consultation Response DG Research Green Paper on the Common Strategic Framework
- 13 May 2011 HAI Europe Consultation Response – Clinical Trial Directive
- 31 Mar 2011 HAI Europe Response to DG Internal Market Consultation on the IP RED Directive
- 2010
- 22 Mar 2010 HAI Europe Response to DG Trade Consultation on ACTA
- 2009
- 1 Dec 2009 HAI Europe Response to EU Role in Global Health Consultation
- 23 Sep 2009 Joint Answer to “The EMEA transparency policy – draft for public consultation”
- 13 Aug 2009 Response to UK MHRA Consultation on ‘Info to Patients’
- 18 Jun 2009 HAI Europe Response HPF Health Impact of Economic Crisis
- 28 May 2009 HAI Europe Response to EMEA Expression of Strength of Medicines
- 18 May 2009 Response to Council of the Regions Pharma Package Consultation
- 2 Mar 2009 HAI Europe Response to EMEA Consultation on Eudravigilance Access Policy
- 27 Feb 2009 HAI Europe Response to EMEA Consultation on Access to Documents
- 31 Jan 2009 DG Competition Consultation on European Pharmaceutical Industry
- 2008
- 7 Apr 2008 HAI Europe Response to EU Commissions proposal on ‘information’ to patients
- 1 Feb 2008 HAI Europe Response to DG Enterprise Pharmacovigilance Consultation (FR)
- 1 Feb 2008 HAI Europe Response to DG Enterprise Pharmacovigilance Consultation
- 21 Jan 2008 HAI Europe response to Future Challenges consultation DG Sanco
- 2007
- 1 Oct 2007 HAI Europe Response to EU Commission consultation on the Future of Pharmaceuticals
- 21 Sep 2007 HAI Europe response to the consultation on the review of Variations regulation
- 28 June 2007 HAI Europe response to the draft report on current practises of information to patients
- 14 June 2007 Joint concerns Patient information in Europe: many concerns
